STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 253 Dimensions

Readers on

mendeley: 242 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 13 X posts from 7 X users, with an upper bound of 13,767 followers.

RT @JournalofExper1: TOP 3 Most Cited 2019 1. Combination of CTLA-4 and PD-1 blockers for treatment of cancer https://t.co/s44l22UaN1 2.…

06 Jan 2021

Reply Repost Favourite

RT @JournalofExper1: TOP 3 Most Cited 2019 1. Combination of CTLA-4 and PD-1 blockers for treatment of cancer https://t.co/s44l22UaN1 2.…

31 Dec 2020

Reply Repost Favourite

RT @JournalofExper1: TOP 3 Most Cited 2019 1. Combination of CTLA-4 and PD-1 blockers for treatment of cancer https://t.co/s44l22UaN1 2.…

30 Dec 2020

Reply Repost Favourite

TOP 3 Most Cited 2019 1. Combination of CTLA-4 and PD-1 blockers for treatment of cancer https://t.co/s44l22UaN1 2. Advances in cancer immunotherapy 2019 https://t.co/TdRfZXS0Zq 3. STAT3 as a potential therapeutic target in triple negative breast cancer

30 Dec 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.